14 September 2021
DeepMatter Group Plc
Notice of half year results and investor presentation
DeepMatter Group Plc (AIM: DMTR, "DeepMatter", the "Group"), the international digital chemistry data company, will be publishing its results for the six months to 30 June 2021 on Wednesday 22 September 2021.
DeepMatter's CEO, Mark Warne, and CFO, Fraser Benson, will provide a live investor presentation via the Investor Meet Company platform on Wednesday 22 September 2021 at 9.30am UK time.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet DeepMatter via
https://www.investormeetcompany.com/deepmatter-group-plc/register-investor.
Investors who have already registered and follow DeepMatter will be automatically invited.
For more information:
DeepMatter Group Plc
Mark Warne, Chief Executive Officer 0141 548 8156
Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000
Bobbie Hilliam
Meare Consulting 07990 858548
Adrian Duffield
About DeepMatter Group Plc
DeepMatter is building a unique, fully integrated digital chemistry cloud platform of chemical reaction data for scientists, who are working on early-stage chemical discovery & development.
DeepMatter is integrating technology with chemistry to enable scientists, principally in the commercial sector, to easily perform and optimise chemistry. It is building, structuring and analysing chemical reaction databases and using this substantial data for real-time innovation and productivity gains in the chemical industry - particularly pharmaceutical companies engaged in pre-clinical drug discovery & development. This data is also now enabling Artificial Intelligence (AI) driven chemical automation.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
